« Previous
Next »
American Journal of Kidney Diseases
Volume 55, Issue 2
, Pages
217-222
, February 2010
The 2009 Proposed Rule for Prospective ESRD Payment: Historical Perspectives and Public Policies—Bundle Up!
-
Total Medicare direct costs of the ESRD program (bars), including dialysis and transplant but not including costs to Medicare health maintenance organizations (HMOs) and Medicare patient obligations,
Total Medicare direct costs of the ESRD program (bars), including dialysis and transplant but not including costs to Medicare health maintenance organizations (HMOs) and Medicare patient obligations, and the numbers of incident and prevalent dialysis patients (not including transplant) in the United States from 1995-2007. Produced using data from the 2009 USRDS Annual Data Report.1
-
Mean erythropoietin dose per administration during the initial 6 months of each year, 1991-2006. Source: General Accounting Office.18Mean erythropoietin dose per administration during the initial 6 months of each year, 1991-2006. Source: General Accounting Office.18
This article is part of a series in the February 2010 issue of AJKD that explores the 2009 proposed rule for the Medicare ESRD prospective payment system.
PII: S0272-6386(09)01574-1
doi: 10.1053/j.ajkd.2009.12.005
© 2010 National Kidney Foundation, Inc. All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 55, Issue 2
, Pages
217-222
, February 2010
